Lemaitre Vascular (LMAT) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 +9.08%
Financial Fact:
Cash dividends declared per common share: 0.05
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Cash dividends declared per common share: 0.05
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $41.39 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Revolution Medicines, Inc. (RVMD) Tops Q3 EPS by 45c ; Provides Outlook
- CrossAmerica Partners (CAPL) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
